LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V., (NASDAQ:OFIX) today announced that it has appointed David E. Ziegler as Interim Chief Financial Officer (CFO). Mr. Ziegler succeeds Emily Buxton who has voluntarily resigned from the Company. Orthofix and its Board of Directors are conducting an executive search to identify a permanent CFO.
Mr. Ziegler has served as a full-time independent advisor to the Audit Committee of the Board in connection with the independent review of certain accounting matters. In that capacity, he assisted Orthofix and its finance department in their preparation of the Company’s recently filed financial statement restatement, and subsequent reporting of 2013 financial results.
“Emily has been a dedicated and tireless team member for more than 11 years. I want to thank her for the hard work and contributions she has made to the Company and we wish Emily success in her new endeavors,” said President and Chief Executive Officer Brad Mason. “Additionally, I am confident with David’s strong financial and accounting background and successful track record serving in several interim CFO positions, that he will be an excellent contributor in this role.”
David E. Ziegler
With more than 40 years’ experience, Mr. Ziegler has held a wide range of CFO and consulting roles including serving as interim Chief Financial Officer of, and transition consultant to, Exopack Holding Corp., and a financial consultant to PetroLogistics LLC, Critical Information Network, LLC, and Lighting Science Group Corporation. He also served as CFO and interim President of The UniMark Group, Inc. Mr. Ziegler spent the first 20 years of his career as an auditor with Arthur Andersen, the last eight as an audit partner in its Detroit and Dallas offices.
Mr. Ziegler received his Bachelor of Arts degree in Accounting and Finance, along with a Minor in Economics, from Michigan State University, and currently serves as a director of the Grant Halliburton Foundation, a non-profit organization located in Dallas, Texas. Mr. Ziegler has been a licensed certified public accountant in the State of Texas since 1981.
Orthofix International N.V. is a diversified, global medical device company focused on improving patients’ lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. Headquartered in Lewisville TX, the company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Orthofix products are widely distributed via the company’s sales representatives, stocking distributors and subsidiaries. In addition, Orthofix is collaborating on research and development activities with leading clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation and the Texas Scottish Rite Hospital for Children. For more information, please visit www.orthofix.com.